Overview

Phase II Trial With Metronomic, Capecitabine Plus Oral Vinorelbine for Metastatic Breast Cancer

Status:
Completed
Trial end date:
2015-03-01
Target enrollment:
Participant gender:
Summary
The study hypothesis is that metronomic treatment is more efficient than standard treatment.
Phase:
Phase 2
Details
Lead Sponsor:
University of Aarhus
Collaborator:
Pierre Fabre Laboratories
Treatments:
Capecitabine
Vinblastine
Vinorelbine